NCT00067808 Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2
NCT00067028 Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML) Status COMPLETED Phase PHASE2
NCT00064584 Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML) Status COMPLETED Phase PHASE1
NCT00057031 Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS) Status UNKNOWN Phase PHASE2
NCT00050154 Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2
NCT00048958 Cytogenetic Studies in Acute Leukemia and Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT00045786 Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic Syndromes Status COMPLETED Phase PHASE2
NCT00044382 Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome Status COMPLETED Phase PHASE2
NCT00043810 Study of Gelonin Purging of Autologous Stem Cells for Transplantation Status TERMINATED Phase PHASE1/PHASE2
NCT00043381 Decitabine Versus Supportive Care in Adults With Advanced-stage MDS Status COMPLETED Phase PHASE3
NCT00038831 Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS Status COMPLETED Phase PHASE1/PHASE2
NCT00013533 Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies Status COMPLETED Phase EARLY_PHASE1
NCT00005937 Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia Status COMPLETED Phase PHASE2
NCT00003838 Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow Status COMPLETED Phase PHASE2
NCT00001873 The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers Status COMPLETED Phase PHASE2
NCT00001637 Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults Status COMPLETED Phase PHASE2
NCT00001623 Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia Status COMPLETED Phase NA